Drugmakers to Raise Prices on 350+ U.S. Medicines Despite Trump Pressure
U.S. pharmaceutical companies are poised to raise prices on hundreds of prescription drugs in 2026, a move that highlights friction between industry practices and President Trump’s push to lower drug costs.
Even as the White House has publicly advocated for cheaper medicines, major drugmakers are planning price hikes that could affect Americans at the pharmacy counter early next year.
Confirmed Reuters data shows at least 350 branded medications are slated for list-price increases, including vaccines for COVID-19, RSV and shingles and blockbuster treatments like Ibrance for cancer.
The median cost bump is roughly 4%, mirroring increases seen at the start of 2025, while some companies are offering price cuts on a handful of products, including certain diabetes therapies.
This development comes amid Trump’s campaign statements vowing to slash drug prices, including executive actions on “most favored nation” pricing and the rollout of a federal prescription drug platform.
Follow The Coffman Chronicle on NewsBreak for daily breaking political coverage.
“The reality is that without structural legislative change, market pricing dynamics will continue to outweigh political rhetoric,” said a healthcare policy analyst tracking pharmaceutical cost trends.
The divergence between Trump’s rhetoric and real-world pricing adjustments matters because drug costs are a significant out-of-pocket burden for many Americans, especially those on fixed incomes or without comprehensive insurance. Rising list prices can translate directly into higher copays and deductibles at the pharmacy counter.
Industry leaders argue that rising manufacturing, supply chain and R&D costs necessitate price adjustments, but critics say incremental cuts on a few drugs do little to offset broad hikes.
With 2026 price frameworks now set, the next major milestone will be how insurers, Medicare and policymakers respond in the coming legislative session.
Pharmacy counters nationwide could feel the impact as patients refill prescriptions in the new year.
Follow The Coffman Chronicle on NewsBreak for daily breaking political coverage.